BDNF and melanoma: The most promising lncRNA candidates (BDNF-AS, GDMS-AS1, and XLOC_030781) that were selected from screen 1.0 maintained comparable rankings in screen 2.0, thereby reinforcing their selection in terms of robustness and significance for melanoma cell survival (Supplementary Table S3) and pointing to no prior drop-off due to Dox induction of dCas9-KRAB.